GRI Bio, Inc. Share Price
NASDAQ: GRI | Micro CapGRI Bio, Inc. Stock Performance
GRI Bio, Inc. Share Price Chart
GRI Bio, Inc. Quarterly Profit & Loss
All figures in USD
GRI Bio, Inc. Annual Profit & Loss
All figures in USD
About GRI Bio, Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
GRI Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.96 | $1.88 | -12.79% |
Sep 2026 | $1.94 | $2.15 | +2.87% |
Aug 2026 | $1.45 | $2.09 | +46.15% |
Jul 2026 | $1.83 | $1.43 | -20.99% |
Jun 2026 | $2.03 | $1.81 | -12.14% |
May 2026 | $2.23 | $2.06 | -8.04% |
Apr 2026 | $2.39 | $2.24 | +0.90% |
Mar 2026 | $2.42 | $2.22 | -12.94% |
Feb 2026 | $3.13 | $2.55 | -21.66% |
Jan 2026 | $0.24 | $3.25 | +1,239.51% |
Dec 2025 | $1.97 | $0.24 | -87.85% |
Nov 2025 | $1.66 | $2.00 | +19.05% |
GRI Share Price FAQs
What is GRI Bio, Inc. share price today?
What is the 52 week high and 52 week low of GRI Bio, Inc. stock?
What is GRI's market capitalisation today?
What is GRI's net income for the last quarter?
What is the 5 year returns of GRI?
What is the high & low stock price of GRI today?
Can I buy GRI shares in India?